BioGend Therapeutics Co Ltd

NEW
ROCO:6733 (Taiwan)   Ordinary Shares
NT$ 25.35 -0.65 (-2.5%) Jul 14
At Loss
P/B:
4.26
Market Cap:
NT$ 3.40B ($ 105.89M)
Enterprise V:
NT$ 2.91B ($ 90.47M)
Volume:
182.10K
Avg Vol (2M):
245.13K
Trade In:
Volume:
182.10K
At Loss
Avg Vol (2M):
245.13K

BioGend Therapeutics Co Ltd Operating Data

BioGend Therapeutics Co Ltd Competitors' Latest Operating Data

Operating data not available.

BioGend Therapeutics Co Ltd (ROCO:6733) Operating Data Charts